Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadThe Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse ModelRecombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.Construction of mobilizable mini-Tn7 vectors for bioluminescent detection of gram-negative bacteria and single-copy promoter lux reporter analysis.Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.Lipopolysaccharide O-antigen chain length regulation in Pseudomonas aeruginosa serogroup O11 strain PA103.Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244Acinetobacter baumannii: emergence of a successful pathogenGlobal challenge of multidrug-resistant Acinetobacter baumanniiGenetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in micePseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protectionSubcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and BordImmunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.Needle-free vaccine delivery.Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms.Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide.Recent developments for Pseudomonas vaccines.A multifunctional bispecific antibody protects against Pseudomonas aeruginosa.Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence.In vivo imaging of bioluminescent Pseudomonas aeruginosa in an acute murine airway infection model.A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.Cross reaction between proteins from Larrea divaricata Cav. (jarilla) and cellular and extracellular proteins of Pseudomonas aeruginosa.
P2860
Q26852817-8E11B3D6-C1F8-4FFB-B5E8-B9AA7B4A984FQ27313397-0FA402E2-3800-4594-AA67-C2B5A9D0C153Q30279061-E0D4D5B1-62CF-4A93-BA80-B3E9794BC3E1Q30408273-CF2E4B9E-C6DA-40B4-9642-D15A112A3D21Q30415438-F0C7B875-F990-40CD-9727-138F504A0718Q30423024-70D7D095-BB4B-4936-8133-B73F8EE80D21Q30441316-78F2BD27-4D2D-4266-81EA-40207E904185Q30441643-7622E8F2-89E7-4B5E-86ED-2A81EA00E1D3Q33564290-2F302E45-3026-416B-BE34-2CB8244914A5Q33613907-D144205A-B6EA-49AB-A551-BEF4EE9C89DCQ34291197-561F6F0F-4212-472B-B595-0B3BE6152691Q34795807-1C3667F4-26FB-489B-AF3F-C35B26905C44Q36095081-AD121BC8-F90F-4CD3-8D11-F5EFDD4778B0Q36147444-3BA7E5AA-D9FA-48FF-80AA-172C9D43E170Q36391313-DFB73797-5A1D-4825-98B6-1DECE2EB2B1CQ36487854-1284E561-C884-4E05-B1AB-84FD27AB5CDEQ36539114-432B2792-6943-4F9A-8E0E-5D86780693D8Q36594009-3F5A8830-D7B4-410A-9E52-C8ED2E3E3B49Q36676050-35E7A28A-84F7-484E-979E-A1AE02BB498CQ36945838-7A3AB01B-3EB4-4249-8A6E-00BDD0F5A8BAQ36968815-8E1E06D8-D674-4E18-90ED-93A82423792FQ37111626-8D154CED-18CA-413C-A17A-5DB28EC71E23Q37713368-920030EC-AB23-4A24-8A9C-F839D3C3AF88Q37891784-104B13CD-37BE-4AF4-A9D9-E7B77FC07D2EQ37937369-1FB7F01E-B73B-428E-81B2-6084F4F9D74DQ38940907-19E434EB-F310-467B-ACB6-648D15961469Q42119085-F5AD13C3-6C93-44BC-A13C-C65FDB1A0094Q42215058-DF56E76D-6E2C-45DD-ACF4-C39DF941B781Q43121719-2C7732EF-E087-4C84-B2CC-7C569A371063Q45174642-EA2A1468-1E37-4AAB-8CAF-45B9232CBB06Q46091425-C6E3DCF7-26F3-4F19-A3D2-9028E251E198
P2860
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Intranasal immunization with h ...... domonas aeruginosa infections.
@ast
Intranasal immunization with h ...... domonas aeruginosa infections.
@en
type
label
Intranasal immunization with h ...... domonas aeruginosa infections.
@ast
Intranasal immunization with h ...... domonas aeruginosa infections.
@en
prefLabel
Intranasal immunization with h ...... domonas aeruginosa infections.
@ast
Intranasal immunization with h ...... domonas aeruginosa infections.
@en
P2093
P2860
P921
P356
P1476
Intranasal immunization with h ...... domonas aeruginosa infections.
@en
P2093
Alice N Neely
Antonio DiGiandomenico
Jason Gardner
Jayasimha Rao
Joanna B Goldberg
Katie Harcher
Tanweer S Zaidi
P2860
P304
P356
10.1073/PNAS.0608657104
P407
P50
P577
2007-03-05T00:00:00Z